sory committee voted (=5 yes, 5 no, 1 abstention) to update the safety information in the label of=celecoxib, a nonsteroidal anti-inflammatory drug (NSAID), for use in patien=s with osteoarthritis (OA) and rheumatoid arthritis, on the basis of result= of the PRECISION trial. A Joint Meeting o=the Arth